🇺🇸 FDA
Pipeline program

Oral Chondroitin Sulfate (Flextrum)

1.0 10.10.2019

Unknown other completed

Quick answer

Oral Chondroitin Sulfate (Flextrum) for Meniscus Lesion is a Unknown program (other) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).

Program details

Company
COLLEGIUM PHARMACEUTICAL, INC
Indication
Meniscus Lesion
Phase
Unknown
Modality
other
Status
completed

Clinical trials